A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

NCT07332000 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Patients Treated by Radiotherapy
Prostate Cancer (Adenocarcinoma)

Interventions

BIOLOGICAL: aglatimagene besadenovec + valacyclovir
RADIATION: External Beam Radiation Therapy (EBRT)

Sponsor

Candel Therapeutics, Inc.